Loading
Episurf Medical AB (publ) Stock: price and insider trades · Sweden
Episurf Medical AB (publ): what insiders have been doing
Episurf Medical AB (publ) is a listed company. Its directors and officers file their transactions with Finansinspektionen. In the past year (19 October 2025 to 19 October 2026), 6 filings came from 2 insiders.
Only sales appear on the open market, 6 sales in all totalling €3.6M, filed by 2 insiders. At €3.5M, the sale published on 15 September 2026 by Mofast AB (Publ) is the largest of the period (3.4% of market cap).
Filings reach the Finansinspektionen feed a median of 1 day after the trade. The legal deadline for notifying a trade is three business days (MAR article 19). Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
Across the 880 companies tracked on its exchange, the median is 8 filings; at 6 filings, this issuer sits below that mark. Our records for Episurf Medical AB (publ) go back to 2017, with no purchases and 9 sales on the open market in total.
Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Insider Decl.
9
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€5M
9 ops. · all time
Who traded when
BuySalePatrick Jamnik4 sales
Mofast AB (Publ)2 sales
Fundamental score
Ranked 19,878 of 26,316 companies
33.9
score / 100
Value21
Quality47
FCF yld-5.7%
Earn yld-5.3%
EV/EBITDA·
ROE-91%
Gross mgn75%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
SEK 0.07
Analyst consensus
Income statement
RevenueSEK 13.5M
Gross profitSEK 10.1M75% margin
EBITDA-SEK 49.3M-365% margin
Net income-SEK 58.2M-431.1% margin
Valuation
P/Book0.8x
Beta0.90
Balance sheet & cash
Market capSEK 1.1B
Total debtSEK 4.9M
Free Cash Flow-SEK 62M
Debt / Equity104%
Profitability & ownership
ROE-91.1%
ROA-3.9%
% insiders37.1%
% institutions4.1%
Last declaration on 15 September 2026
Declarations9 total
12,500,000 shares@ SEK 0.07750.084% mcap2.4% of flowAktieISIN SE0003491562FI:csv-2d7234f5e8e196551910
600,000,000 shares@ SEK 0.0653.42% mcap97.6% of flowAktieISIN SE0003491562FI:csv-9cabd5cded0191db2b27
335,231 shares@ SEK 0.08280.0025% mcap17.9% of flowAktieISIN SE0003491562FI:csv-bfb25c135b3b7687ac4a
1,500,000 shares@ SEK 0.08150.011% mcap78.8% of flowAktieISIN SE0003491562FI:csv-5afc32c2b864ca624d91
18,935 shares@ SEK 0.08320.0001% mcap1.0% of flowAktieISIN SE0003491562FI:csv-83aef3cae2626c7007bd
43,259 shares@ SEK 0.08310.0003% mcap2.3% of flowAktieISIN SE0003491562FI:csv-517e391543ea4f228b76
60,000 shares@ SEK 5.75FI:csv-8480f834225badb3331b
983,607 shares@ SEK 6.10FI:csv-22fba06da171b6d7d343
983,607 shares@ SEK 6.10ISIN SE0003491562FI:csv-54716cd9daa5e11eb206
9 of 9 declarations
About Episurf Medical AB (publ)
Episurf Medical AB (publ) is a Swedish company focused on developing medical solutions for joint injuries, particularly through customized implants. The company is listed on the XSTO market.